Insider Ledger

VCEL insider buying and SEC filings, explained

Vericel Corp · CIK 887359

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$517K
Planned sales (10b5-1)
$7.4M

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Aug 12, 2026Planned (10b5-1)Kevin F. Mclaughlin (Director) sold 7,000 shares at $44.53 ($312K), marked as a 10b5-1 plan trade. Holdings down 28% to 18,300 shares.SEC filing
Filed Aug 14, 2026
Aug 3, 2026Planned (10b5-1)Michael Halpin (President / COO) sold 10,000 shares at $46.84 ($468K), marked as a 10b5-1 plan trade. Holdings down 38% to 16,394 shares.SEC filing
Filed Aug 5, 2026
Jul 30, 2026Planned (10b5-1)Jonathan Siegal (Principal Accounting Officer) sold 4,500 shares at $48.90 ($220K), marked as a 10b5-1 plan trade. Holdings down 81% to 1,078 shares.SEC filing
Filed Jul 31, 2026
Jun 26, 2026Planned (10b5-1)Jonathan Siegal (Principal Accounting Officer) sold 2,732 shares at $44.90 ($123K), marked as a 10b5-1 plan trade. Holdings down 76% to 886 shares.SEC filing
Filed Jun 30, 2026
Jun 26, 2026Planned (10b5-1)Joseph Anthony Mara Jr (CFO) sold 5,000 shares at $44.75 ($224K), marked as a 10b5-1 plan trade. Holdings down 24% to 16,009 shares.SEC filing
Filed Jun 30, 2026
Jun 26, 2026Planned (10b5-1)Jonathan Mark Hopper (Chief Medical Officer) sold 10,000 shares at $45.00 ($450K), marked as a 10b5-1 plan trade. Holdings down 12% to 75,753 shares.SEC filing
Filed Jun 30, 2026
Jun 26, 2026Planned (10b5-1)Sean C. Flynn (Chief Legal Officer) sold 15,000 shares at $45.64 ($685K), marked as a 10b5-1 plan trade. Holdings down 90% to 1,647 shares.SEC filing
Filed Jun 30, 2026
Jun 18, 2026Planned (10b5-1)Michael Halpin (President / COO) sold 10,000 shares at $40.24 ($402K), marked as a 10b5-1 plan trade. Holdings down 38% to 16,248 shares.SEC filing
Filed Jun 22, 2026
Jun 18, 2026Planned (10b5-1)Sean C. Flynn (Chief Legal Officer) sold 15,000 shares at $40.21 ($603K), marked as a 10b5-1 plan trade. Holdings down 90% to 1,647 shares.SEC filing
Filed Jun 22, 2026
Jun 2, 2026Planned (10b5-1)Jonathan Mark Hopper (Chief Medical Officer) sold 4,375 shares at $35.00 ($153K), marked as a 10b5-1 plan trade. Holdings down 5% to 75,753 shares.SEC filing
Filed Jun 4, 2026
May 13, 2026Planned (10b5-1)Kevin F. Mclaughlin (Director) sold 7,000 shares at about $32.83 ($230K), marked as a 10b5-1 plan trade. Holdings down 28% to 18,300 shares.SEC filing
Filed May 15, 2026
May 11, 2026SalePaul K Wotton (Director) sold 10,000 shares at about $32.74 ($327K). Holdings down 35% to 18,802 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 13, 2026
May 7, 2026Planned (10b5-1)Joseph Anthony Mara Jr (CFO) sold 5,000 shares at $40.50 ($203K), marked as a 10b5-1 plan trade. Holdings down 19% to 21,009 shares.SEC filing
Filed May 8, 2026
May 6–7, 2026Planned (10b5-1)Jonathan Siegal (Principal Accounting Officer) sold 4,855 shares between May 6 and May 7 at about $38.73 ($188K), marked as a 10b5-1 plan trade. Holdings down 81% to 1,118 shares.SEC filing
Filed May 8, 2026
Apr 2, 2026Planned (10b5-1)Jonathan Mark Hopper (Chief Medical Officer) sold 3,472 shares at $35.00 ($122K), marked as a 10b5-1 plan trade. Holdings down 4% to 75,556 shares.SEC filing
Filed Apr 6, 2026
Mar 23, 2026Planned (10b5-1)Heidi Hagen (Director) sold 15,000 shares at $32.41 ($486K), marked as a 10b5-1 plan trade. Holdings down 32% to 31,850 shares.SEC filing
Filed Mar 25, 2026
Mar 2, 2026Planned (10b5-1)Sean C. Flynn (Chief Legal Officer) sold 21,421 shares at about $35.18 ($754K), marked as a 10b5-1 plan trade. Holdings down 94% to 1,262 shares.SEC filing
Filed Mar 4, 2026
Mar 2, 2026Planned (10b5-1)Michael Halpin (President / COO) sold 10,305 shares at $35.30 ($364K), marked as a 10b5-1 plan trade. Holdings down 39% to 16,080 shares.SEC filing
Filed Mar 4, 2026
Feb 11, 2026Planned (10b5-1)Kevin F. Mclaughlin (Director) sold 7,000 shares at $34.66 ($243K), marked as a 10b5-1 plan trade. Holdings down 32% to 15,100 shares.SEC filing
Filed Feb 13, 2026
Jan 7, 2026Planned (10b5-1)Michael Halpin (President / COO) sold 10,000 shares at $40.48 ($405K), marked as a 10b5-1 plan trade. Holdings down 38% to 16,080 shares.SEC filing
Filed Jan 9, 2026
Dec 2, 2025Planned (10b5-1)Jonathan Mark Hopper (Chief Medical Officer) sold 1,652 shares at $39.14 ($65K), marked as a 10b5-1 plan trade. Holdings down 2% to 66,562 shares.SEC filing
Filed Dec 4, 2025
Dec 2–3, 2025SalePaul K Wotton (Director) sold 5,000 shares between Dec 2, 2025 and Dec 3, 2025 at about $37.90 ($190K). Holdings down 16% to 25,602 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Dec 4, 2025
Nov 11, 2025Planned (10b5-1)Michael Halpin (President / COO) sold 2,642 shares at $40.41 ($107K), marked as a 10b5-1 plan trade. Holdings down 14% to 15,932 shares.SEC filing
Filed Nov 13, 2025
Nov 10, 2025Planned (10b5-1)Kevin F. Mclaughlin (Director) sold 7,000 shares at $38.59 ($270K), marked as a 10b5-1 plan trade. Holdings down 32% to 15,100 shares.SEC filing
Filed Nov 12, 2025
Nov 6, 2025Planned (10b5-1)Michael Halpin (President / COO) sold 7,358 shares at $40.47 ($298K), marked as a 10b5-1 plan trade. Holdings down 32% to 15,932 shares.SEC filing
Filed Nov 10, 2025

44 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow VCEL in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app